|
|
|
Chinese scientist charged with visa fraud appears in court
Legal News Feed |
2020/07/25 08:53
|
A Chinese scientist charged with visa fraud after authorities said she concealed her military ties to China in order to work in the U.S. made her first appearance Monday in federal court by video.
Juan Tang, 37, was appointed a federal public defender and U.S. Magistrate Judge Deborah Barnes ordered Tang to remain in custody, saying she is a flight risk, while her attorney prepares an argument to allow her release on bail.
The Justice Department last week announced charges against Tang and three other scientists living in the U.S., saying they lied about their status as members of China’s People’s Liberation Army. All were charged with visa fraud.
Prosecutors said Tang lied about her military ties in a visa application last October as she prepared to work at the University of California, Davis and again during an FBI interview in June. Agents found photos of Tang dressed in military uniform and reviewed articles in China identifying her military affiliation, prosecutors said.
Prosecutors said Tang sought refuge at the Chinese consulate in San Francisco after speaking with agents in June. U.S. marshals arrested her Friday and booked her into Sacramento County Jail, where she remains.
Heather Williams, a federal defender, said its common practice for people to seek help from their consulate when dealing with law enforcement abroad, and doing so did not make Tang guilty of anything, she said. Williams added that U.S. agents took Tang's passport, forcing her young daughter to travel to China alone. |
|
|
|
|
|
Oklahoma high court: Governor overstepped with tribal deal
Court News |
2020/07/22 10:50
|
Oklahoma Gov. Kevin Stitt overstepped his authority when he reached a casino gambling agreement with two Native American tribes, the state Supreme Court ruled Tuesday.
In a 7-1 decision, the high court determined the compacts Stitt signed with the Comanche Nation and Otoe-Missouria Tribes are “invalid under Oklahoma law.”
The deals would have allowed the two tribes to offer wagering on sporting events and house-banked card and table games. The compacts also would have allowed the tribes to construct new casinos closer to larger population centers, and would have given the state a larger share of casino revenues from those new casinos. The U.S. Department of the Interior gave tacit approval to the compacts in June following the expiration of a 45-day review period.
But because wagering on sporting events and house-banked card and table games haven’t been authorized by the Legislature, any revenue from such games is prohibited, the court ruled.
“The court must, therefore, conclude Governor Stitt exceeded his authority in entering into the tribal gaming compacts with the Comanche Nation and Otoe-Missouria Tribes that included Class III gaming prohibited by the State-Tribal Gaming Act," the court wrote.
Otoe-Missouria Tribe Chairman John R. Shotton said in a statement that the Oklahoma Supreme Court doesn't have the jurisdiction to invalidate the tribe's compact.
“We have said all along we do not plan to offer house-banked card and table games and event wagering until they are authorized by state law," Shotton added. “Indeed, this condition was part of the compact, and it was unfortunately overlooked by the court."
Stitt said the court's decision, along with a recent U.S. Supreme Court ruling that determined much of eastern Oklahoma remains an American Indian reservation, leaves much work to be done with the tribes. |
|
|
|
|
|
California court upholds verdict in Monsanto cancer case
Legal Line News |
2020/07/21 10:50
|
A California appeals court on Monday upheld a groundbreaking verdict that Monsanto’s widely used weed killer caused cancer in a school groundskeeper but the panel also slashed the damage award from $78.5 million to $21.5 million.
The 1st District Court of Appeal said there was evidence to support a California jury’s 2018 decision that “Monsanto acted with a conscious disregard for public safety,” but it reduced the damages to Dewayne Johnson of Vallejo because state law doesn’t allow damages for reduced life expectancy, the San Francisco Chronicle reported.
The original San Francisco Superior Court jury found that St. Louis-based Monsanto had purposely ignored warnings and evidence that glyphosate, the active ingredient in its popular Roundup and Ranger Pro products, causes cancer.
Johnson, then 46, alleged that his non-Hodgkin’s lymphoma was caused by his years of spraying Ranger Pro on school grounds in Benicia.
Jurors awarded Johnson $289.2 million but a judge later reduced the punitive damages, knocking down the total to $78.5 million.
In further reducing the total award, the appellate court ruled 3-0 that state law entitled Johnson only to compensation for future harm he was “reasonably certain” to suffer. He had been given only two to three years to live.
R. Brent Wisner, a lawyer for Johnson, said the ruling was an overall victory but the court shouldn’t have reduced the damage award.
“This effectively rewards a defendant for killing a plaintiff, as opposed to just injuring him,” Wisner told the Chronicle.
Bayer AG, the German corporation that owns Monsanto, called the reduction “a step in the right direction” but said the appellate panel should have thrown out the verdict and said it may appeal to the California Supreme Court. |
|
|
|
|
|
Justice Ginsburg says cancer has returned, but won’t retire
Legal Line News |
2020/07/19 08:20
|
Justice Ruth Bader Ginsburg said Friday she is receiving chemotherapy for a recurrence of cancer, but has no plans to retire from the Supreme Court.
The 87-year-old Ginsburg, who has had four earlier bouts with cancer including pancreatic cancer last year, said her treatment so far has succeeded in reducing lesions on her liver and she will continue chemotherapy sessions every two weeks “to keep my cancer at bay.”
“I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that,” Ginsburg said in a statement issued by the court.
Ginsburg, who was appointed by President Bill Clinton in 1993, is the senior liberal justice on a court that leans conservative by a 5-4 margin. Her departure before the election could give President Donald Trump the chance to shift the court further to the right.
Ginsburg’s history with cancer goes back more than 20 years. In addition to being treated without surgery for a tumor on her pancreas last year, she also underwent surgery for colorectal cancer in 1999, pancreatic cancer in 2009 and lung cancer in December 2018.
Dr. Alan Venook, a pancreatic cancer specialist at the University of California, San Francisco, who is not involved in Ginsburg’s care, said that “clearly, she’s got incurable disease now” because of the spread to her liver.
On average, patients with advanced pancreatic cancer live about a year, but the fact that her disease took so long to recur from her initial pancreatic cancer surgery in 2009 and previous treatments “suggests that it’s not been growing rapidly,” he said.
“She’s above average in many ways.” and has done remarkably well with all her treatments so far, Venook said. “There’s no reason to think she would die imminently.”
Asked earlier this week about a possible opening on the court before the election, White House chief of staff Mark Meadows said the president would act quickly if any opening were to arise. Meadows commented after news that Ginsburg had left the hospital after receiving treatment for an infection, which she said Friday was unrelated to the cancer.
“I can’t imagine if he had a vacancy on the Supreme Court that he would not very quickly make the appointment and look for the Senate to take quick action,” Meadows said, adding that he didn’t want any comment to be seen as wishing Ginsburg “anything but the very best.”
Senate Majority Leader Mitch McConnell, R-Ky., has said that if there were to be a vacancy on the court during this year’s election cycle, the Republican-controlled Senate would likely confirm a nominee selected by Trump.
Ginsburg said she was disclosing her cancer treatment now because she is satisfied “that my treatment course is now clear.”
Venook said the chemotherapy drug Ginsburg said she is getting, gemcitabine, is one that’s often used. Immunotherapy, which Ginsburg’s statement said she tried unsuccessfully, has not worked well for pancreatic cancer, Venook said.
Ginsburg said a medical scan in February revealed growths on her liver and she began chemotherapy in May.
“My most recent scan on July 7 indicated significant reduction of the liver lesions and no new disease,” she said. “I am tolerating chemotherapy well and am encouraged by the success of my current treatment.” |
|
|
|
|